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There were 4  452 maternal deaths in South Africa 
(SA) for the period 2011 - 2013.[1] The institutional 
maternal mortality ratio (iMMR) in SA decreased from 
176.22/100 000 live births in the 2008 - 2010 triennium 
to 154.06/100 000 for 2011 - 2013, but further work 
needs to be done to meet the fifth Millennium Development Goal. In 
order to reduce maternal mortality, it is important to understand the 
process of obstetric care, identify weaknesses within the system, and 
finally implement interventions for improving care.[2]
A woman who experiences and survives a severe health condition 
during pregnancy, during childbirth or after delivery is classified 
as a maternal near miss.[3] By studying cases of maternal deaths 
and near misses, important information can be obtained about 
the processes that take place in healthcare systems responsible 
for the care of pregnant women. While near-miss cases share 
many pathological and circumstantial characteristics with maternal 
deaths, they provide additional information about obstacles that 
have to be overcome after the onset of an acute complication. [2,4] 
Although a maternal near-miss case can only be identified 
retrospectively, it is clinically useful to prospectively identify 
women with potentially life-threatening conditions. A woman who 
develops a life-threatening condition will either become a maternal 
near-miss case or a maternal death.
Objectives
To determine the spectrum of severe maternal morbidity and mor-
tality in the Pretoria Academic Complex (PAC), SA, and compare 
the data with previous surveys and the World Health Organization 
(WHO) Multicountry Survey on Maternal and Newborn Health.[5] 
The WHO study was used as a comparison because it is the only 
study to characterise maternal morbidity occurring in a worldwide 
network of health facilities.
Methods
This was a descriptive population-based study that took place from 
1 August 2013 to 31 July 2014 at nine delivery facilities in central, 
south-western and eastern Tshwane, Gauteng Province, SA. The 
following delivery units were included in the study: Steve Biko 
Academic Hospital (SBAH) (level 3), Kalafong Provincial Tertiary 
Hospital Hospital (KAH) (level 3), Mamelodi Hospital (level 2), 
Tshwane District Hospital (TDH) (level 1), Pretoria West Hospital 
(level 1), Laudium Community Health Centre (CHC) with midwife 
obstetric unit (MOU), Eersterust MOU, and Stanza Bopape and Dark 
City clinics (CHCs). SBAH and KAH are tertiary referral hospitals 
that receive referrals from outside Gauteng, but data were only 
analysed for women living in the Tshwane region; those living outside 
were excluded. Cases of abortion and ectopic pregnancy were also 
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Background. In order to reduce maternal mortality in South Africa (SA), it is important to understand the process of obstetric care, identify 
weaknesses within the system, and implement interventions for improving care.
Objective. To determine the spectrum of maternal morbidity and mortality in the Pretoria Academic Complex (PAC), SA.
Methods. A descriptive population-based study that included all women delivering in the PAC. The World Health Organization definition, 
criteria and indicators of near miss and maternal death were used to identify women with severe complications in pregnancy.
Results. Between 1 August 2013 and 31 July 2014, there were 26 614 deliveries in the PAC. The institutional maternal mortality ratio was 
71.4/100 000 live births. The HIV infection rate was 19.9%, and 2.7% of women had unknown HIV status. Of the women, 1 120 (4.2%) 
developed potentially life-threatening conditions and 136 (0.5%) life-threatening conditions. The mortality index was 14.0% overall, 30.0% 
for non-pregnancy-related infections, 2.0% for obstetric haemorrhage and 13.6% for hypertension. Of the women with life-threatening 
conditions, 39.3% were referred from the primary level of care. Vascular, uterine and coagulation dysfunctions were the most frequent organ 
dysfunctions in women with life-threatening conditions. The perinatal mortality rate was 26.9/1 000 births overall, 23.1/1 000 for women 
with non-life-threatening conditions, and 198.0/1 000 for women with life-threatening conditions.
Conclusion. About one in 20 pregnant women in the PAC had a potentially life-threatening condition; 39.3% of women presented to a primary 
level facility as an acute emergency and had to be transferred for tertiary care. All healthcare professionals involved in maternity care must have 
knowledge and skills that equip them to manage obstetric emergencies. Review of the basic antenatal care protocol may be necessary.
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excluded from the study. Delivery data were recorded on a daily basis 
at all the health facilities, and daily audit meetings were held at SBAH 
and KAH to identify women with life-threatening conditions and 
organ dysfunction in pregnancy. The following WHO indicators were 
used to quantify women with severe complications in pregnancy:[2,6]
Maternal near miss. A woman who nearly died but survived a 
complication that occurred during pregnancy or childbirth, or within 
42 days of termination of pregnancy. The WHO near-miss criteria are 
listed in Table 1.
Maternal death. A maternal death is the death of a woman while 
pregnant or within 42 days of termination of pregnancy, irrespective 
of the duration and the site of pregnancy, from any cause related to 
or aggravated by the pregnancy or its management, but not from 
accidental or incidental causes.
Life-threatening conditions/severe maternal outcome (SMO). 
This refers to all women who either qualified as having a maternal 
near miss or who died. It is the sum of maternal near misses and 
maternal deaths.
Potentially life-threatening condition. The five potentially life-
threatening conditions described by the WHO are severe postpartum 
haemorrhage, severe pre-eclampsia, eclampsia, sepsis/severe systemic 
infection, and ruptured uterus. The operational definitions of the five 
potentially life-threatening conditions are:
• Severe postpartum haemorrhage. Genital bleeding after delivery, 
with at least one of the following: perceived abnormal bleeding 
(1  000 mL or more) or any bleeding with hypotension or blood 
transfusion.
• Severe pre-eclampsia. Persistent systolic blood pressure of 
≥160  mmHg or a diastolic blood pressure of ≥110 mmHg; 
proteinuria of ≥5 g in 24 hours; oliguria of <400 mL in 24 hours; 
and HELLP (haemolysis, elevated liver enzymes, low platelets) 
syndrome or pulmonary oedema. Excludes eclampsia.
• Eclampsia. Generalised fits in a patient without previous history of 
epilepsy. Includes coma in pre-eclampsia.
• Severe sepsis/systemic infection. Presence of fever (body temperature 
>38oC), a confirmed or suspected infection (e.g. chorioamnionitis, 
septic abortion, endometritis, pneumonia), and at least one of 
the following: heart rate >90 bpm, respiratory rate >20/min, 
leucopenia (white blood cells <4 × 109/L), leucocytosis (white 
blood cells >12 × 109/L).
• Uterine rupture. Rupture of uterus during labour confirmed by 
laparotomy.
Severe maternal outcome ratio (SMOR). This refers to the 
number of women with life-threatening conditions per 1 000 live 
births. This indicator gives an estimation of the amount of care that 
would be needed in an area.
Mortality index (MI). The number of maternal deaths divided by 
the number of women with life-threatening conditions, expressed as 
a percentage.
Descriptive statistics in the form of means and standard deviations 
in the case of continuous data and frequencies and percentages 
in the case of categorical data were calculated. Ethical approval 
was obtained from the University of Pretoria Ethics Committee 
(No. 125/2013).
Results
There were 26  614 deliveries in the PAC (SBAH, KAH, Mamelodi 
Hospital, TDH, Pretoria West Hospital, Laudium CHC with MOU, 
Eersterust MOU, Stanza Bopape MOU and Dark City clinics) during 
the study period. One hundred and thirty-six women developed 
life-threatening conditions, and there were 19 maternal deaths. The 
SMOR was 5.1/1 000 births and the MI 14.0%. The caesarean section 
rate was 25.2% overall and 61.0% for women with life-threatening 
conditions. The HIV infection rate was 19.9% for the general 
population, 23.1% for near misses and 36.8% for mothers who 
died. HIV status was unknown in 2.7% of patients. The spectrum 
of morbidity from uncomplicated pregnancies to maternal death is 
illustrated in Fig. 1.
Most of the patients with potentially life-threatening and life-
threatening conditions were treated at the two PAC tertiary level 
hospitals. Forty-six women (39.3%) who were classified as near 
misses and 7 (36.8%) who died had to be transferred to the tertiary 
level hospitals after initially presenting at a lower level of care. The 
most frequent indications for emergency transfer of women with 
life-threatening conditions to the tertiary hospitals were severe pre-
eclampsia (15.4%, n=21), obstetric haemorrhage (13.2%, n=18) and 
organ dysfunction in women with underlying medical disease (6.6%, 
n=9) (Table 2). The MI was 18.6% for SBAH, 10.2% for KAH and 
12.5% for Mamelodi Hospital.
Twenty-six women (22.2%) who were classified as a near miss 
had not booked with antenatal care services or had had infrequent 
visits. Medical practitioners caring for these patients believed that 
lack of antenatal care may have contributed to the life-threatening 
event. The distribution of patients with potentially life-threatening 
Table 1. The WHO near-miss criteria[6]
Clinical criteria
Acute cyanosis 
Oliguria unresponsive to fluids or diuretics
Jaundice concomitantly with pre-eclampsia
Shock
Cerebrovascular accident
Breathing rate >40 - <6/min
Loss of consciousness, no pulse/heartbeat
Gasping
Coagulation disorders
Total paralysis
Laboratory criteria
Oxygen saturation <90% for >60 minutes
Creatinine >300 µmol/L or >3.5 mg/dL
Unconscious, presence of glucose and ketoacidosis in urine
PaO2/FiO2 <200 mmHg
Acute thrombocytopenia (platelets <50 × 109/L)
Bilirubin >100 µmol/L or >6.0 mg/dL
Lactate >5 mg/dL
pH <0.1
Management criteria
Use of continuous vasoactive drug
Puerperal hysterectomy due to infection or haemorrhage
Transfusion >5 units of red cell concentrate
Dialysis for treatment of acute kidney failure
Cardiopulmonary resuscitation
Intubation and ventilation for >60 minutes, unrelated to anaesthesia
PaO2/FiO2 = ratio of partial pressure of arterial oxygen and fraction of inspired oxygen.
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conditions in relation to the different levels 
of care is shown in Fig. 2.
The frequency of potentially life-threatening 
disorders is shown in Table 3. (Antepartum 
haemorrhage and non-pregnancy-related 
infections that are not part of the WHO 
definition of potentially life-threatening 
conditions have been included.)
The MI for non-pregnancy-related infections 
was 30.0%, for obstetric haemorrhage 2.0%, 
for hypertension 13.6% and for medical and 
surgical disorders 19.0% (Table 4).
The near-miss markers and distribution 
of organ dysfunction are shown in Tables 
5 and 6. The average age of the women 
who were classified as a near miss was 
30.3 years (minimum 16, maximum 43); 34 
(29.1%) were primigravidas and 83 (70.9%) 
were multigravidas. There were 6 maternal 
deaths related to HIV and AIDS; 4 patients 
had respiratory failure secondary to TB 
pneumonia, 1 had bacterial meningitis and 1 
died after presenting with multiorgan failure 
and milliary tuberculosis. Six women died 
of complications related to pre-eclampsia: 1 
patient had a liver rupture, 2 had intracranial 
bleeds, 2 had respiratory failure due to 
pulmonary oedema and 1 had a cardiac 
arrest. The patient who died as a result of 
postpartum haemorrhage had a placenta 
praevia and had had two previous caesarean 
sections. Although an antenatal ultrasound 
scan had confirmed the location of the 
placenta, the diagnosis of placenta accreta 
was missed. Surgeons encountered a major 
bleed at caesarean section, and despite two 
re-look laparotomies the bleeding could not 
be controlled. Four patients died due to 
underlying medical disease, 1 each due to 
breast cancer, acute-on-chronic pancreatitis 
and an anaesthetic complication in a diabetic 
patient, while the 4th patient had a prosthetic 
heart valve.
There were no maternal deaths at the 
level 1 hospitals or CHCs and only one 
death at a level 2 hospital. This was a patient 
with advanced-stage breast cancer who was 
unable to obtain transport to a tertiary-level 
facility. The MIs for the two tertiary hospitals 
were 18.6% (SBAH) and 10.15% (KAH), and 
that for the level 2 hospital was 12.5%.
Table 7 compares the indices of severe 
acute maternal morbidity at the PAC for 
the periods 1997 - 1998, 2002 - 2004 and 
2013 - 2014. Although the SMOR for the 
general population has remained the same 
since 1997 - 1998, both the iMMR and 
the MI have decreased. These findings are 
consistent for postpartum haemorrhage 
and hypertension. The SMOR for puerperal 
sepsis has remained constant despite the 
HIV epidemic with a decrease in MI. The 
SMOR and MI for medical and surgical 
conditions remain unchanged.
Fig. 3 illustrates the perinatal mortality 
related to maternal morbidity. The women 
with severe maternal morbidity and mortality 
had a much high perinatal mortality rate 
(PNMR); however, for every woman with 
a complicated pregnancy, almost five 
women had no life-threatening condition. 
This explains the relatively small difference 
between the total PNMR and the PNMR of 
the non-life-threatening conditions.
The primary obstetric causes of peri-
natal death were unexplained intrauter-
ine death (30.3%), spontaneous preterm 
labour (25.5%), antepartum haemorrhage 
25 467 (95.70%)
Non-life-threatening conditions
Non-near miss
Severe morbidity
984 (3.70%)
Life-threatening
conditions
136 (0.51%)
Near miss
117 (0.43%)
Maternal death
19 (0.07%)
Potentially life-threatening conditions
1 120 (4.21%)
All pregnancies 26 614
Fig.1. The spectrum of morbidity from uncomplicated pregnancies to maternal death (not drawn to scale).
Table 2. Acute life-threatening conditions necessitating tertiary care (N=136)
Condition
Patients referred to tertiary 
centre from lower levels of care
n (%)
Patients already 
in tertiary care
n (%)
Obstetric haemorrhage 18 (13.2) 26 (19.1)
Pre-eclampsia 21 (15.4) 22 (16.2)
Sepsis 3 (2.2) 11 (8.1)
Medical/surgical disorders 9 (6.6) 9 (6.6)
Non-pregnancy-related infections 3 (2.2) 8 (5.9)
Anaesthetic disorders - 4 (2.9)
Other - 2 (1.5)
Total 54 (39.7) 82 (60.3)
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Fig. 2. Distribution of potentially life-threatening conditions, near misses and maternal deaths in 
relation to the different levels of care.
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(12.3%), intrapartum asphyxia (9.3%), 
hyper tensive disorders (7.4%), fetal abnor-
mality (6.9%) and maternal disease (3.7%).
Discussion
To our knowledge, this is the first study 
in SA assessing the spectrum of morbidity 
for a specific region. There were 26  614 
deliveries over a 12-month period (2013 - 
2014). This represents almost a doubling 
of deliveries since 1997 - 1998, when the 
total number of births for the biennium 
was 27  025, and a 35% increase since 
2002 - 2004 (51  469 births).[7] Just over 
4% of women developed a potentially life-
threatening condition and 0.5% developed 
a life-threatening condition. This is lower 
than the WHO Multicountry Survey on 
Maternal and Newborn Health, which 
reported an incidence of 7% for potentially 
life-threatening conditions and 1% for life-
threatening conditions.[5] However, the 
difference between the two studies was that 
ours was population based while the WHO 
study was hospital based.
About 40% of women with acute life-
threatening conditions did not present 
directly to the two tertiary level hospitals 
during the acute stage of disease. These 
patients were booked at a level 1 or 2 facility 
and then developed an acute condition 
requiring urgent transfer. Similarly, the 
England Collaborative Group reported 
that a significant proportion of serious 
complications occur in women with no 
recognisable risk factors.[8] Severe pre-
eclampsia, obstetric haemorrhage and organ 
dysfunction due to an underlying medical 
condition were the most important reasons 
for emergency transfer. This indicates the 
need to have all healthcare professionals 
involved in care of pregnant women trained 
in the initial stabilisation and management 
of obstetric and neonatal emergencies. The 
antenatal care protocol used in our complex 
is based on the WHO recommendation of 
four antenatal visits for low-risk patients.[9] 
The low frequency of visits possibly means 
Table 3. Frequency of potentially life-threatening disorders
All women 
(N=26 614)
n (%)
Women with SMO 
(N=136)
n (%)
HIV infection in 
women with SMO
n (%)
Severe haemorrhage 660 (2.5) 51 (37.5) 7 (13.7)
Antepartum haemorrhage 301 (1.1) 17 (12.5) 1 (5.9)
Postpartum haemorrhage 336 (1.3) 31 (22.7) 4 (12.9)
Ruptured uterus 23 (0.1) 3 (2.2) 2 (66.7)
Severe hypertensive disorders 682 (2.6) 44 (32.4) 4 (9.1)
Pre-eclampsia 457 (1.7) 40 (29.4) 4 (10.0)
Eclampsia 225 (0.8) 4 (2.9) -
Other complications
Puerperal sepsis 35 (0.1) 14 (10.3) 2 (14.3)
Non-pregnancy-related infections 20 (14.7) 20 (100.0)
Table 4. MIs for different disease conditions
Underlying condition
Maternal 
near miss, n
Maternal 
death, n MI, %
Obstetric haemorrhage 50 1 2.0
Antepartum haemorrhage 17 0 0
Ruptured uterus 3 0 0
Postpartum haemorrhage 30 1 3.2
Hypertension 38 6 13.6
Chronic 1 0 0
Pre-eclampsia 35 4 10.0
Eclampsia 2 2 50.0
Puerperal sepsis 14 0 0
Non-pregnancy-related infections 14 6 30.0
Medical/surgical disorders 17 4 19.0
Table 5. Markers for classification of a maternal near miss (N=117)
Near-miss marker n (%)
Cerebrovascular accident 2 (1.7)
Total paralysis 1 (0.9)
Oxygen saturation <90% for >60 minutes 6 (5.1)
Acute thrombocytopenia (platelets <50 × 109/L) 26 (2.2)
Creatinine >300 µmol/L or > 3.5 mg/dL 4 (3.4)
Bilirubin >100 µmol/L or > 6.0 mg/dL 1 (0.9)
Ketoacids in urine 4 (3.4)
Use of continuous vasoactive drug 3 (2.6)
Dialysis for acute renal failure 2 (1.7)
Hysterectomy following infection or haemorrhage 35 (29.9) (infection 14, haemorrhage 21)
Cardiopulmonary resuscitation 3 (2.6)
Transfusion of >5 units red cells 31 (26.5)
Intubation and ventilation for >60 minutes 18 (15.4)
Table 6. Organ system dysfunction in 
women with life-threatening conditions 
(N=136)*
Dysfunction n (%)
Vascular dysfunction 
(hypovolaemia)
54 (39.7)
Uterine dysfunction 35 (25.7)
Coagulation dysfunction 27 (19.9)
Respiratory dysfunction 24 (17.7)
Cardiovascular dysfunction 9 (6.6)
Immunological dysfunction 8 (5.9)
Renal dysfunction 8 (5.9)
Cerebral dysfunction 7 (5.2)
Hepatic dysfunction 5 (3.7)
Metabolic dysfunction 5 (3.7)
*Some women had more than one organ dysfunction.
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that cases of pre-eclampsia in the early 
stages of the disease process were missed, 
leading to patients presenting at a later stage 
with acute complications requiring tertiary 
care. Early detection of pre-eclampsia may 
require revision of our current antenatal 
care protocol and is supported by the recent 
Cochrane review on patterns of routine 
antenatal care for low-risk pregnancy.[10]
There has been a decrease in the iMMR 
and MI at the PAC since 1997. This has 
been associated with decreases in MI for 
postpartum haemorrhage, hypertension, 
puerperal sepsis and non-pregnancy-related 
infections. The MI for non-pregnancy-
related infections in the PAC was 66.7% 
in 1997 - 1999, 75% in 2000, 47.6% in 
2002 - 2004 and 30% in 2013 - 2014.[8,11] 
The decrease reflects the implementation 
of the antiretroviral programme by the 
National Department of Health and better 
handling of respiratory complications. Of 
significance is the low MI for postpartum 
haemorrhage (3.2%), which is less than half 
of the rate (7.5%) reported in 2002 - 2004 
and significantly lower than the rate (5.3%) 
reported for 1997 - 1998.[11,12] The decrease 
in MI for severe postpartum haemorrhage 
and puerperal sepsis is probably a result 
of the introduction of strict protocols. The 
frequency of postpartum haemorrhage in 
women with life-threatening conditions 
(22.7%) was similar to that in the WHO 
study (26.7%).[6] However, the rates of pre-
eclampsia (29.4%) and non-pregnancy-
related infections (14.7%) were greater in our 
study (WHO 16.3% and 1.6%, respectively). 
The rate of pre-eclampsia in women with 
life-threatening conditions was consistent 
with reports from Nigeria (32.5%) and 
Mozambique (32.9%).[13,14]
Vascular (hypovolaemia), uterine (hyster-
ectomy) and coagulation (low platelets) 
dysfunction were the most frequent organ 
system dysfunctions in women with life-
threatening conditions (Table 6). Many 
women had multiple complications. The 
disease profile in our complex has changed 
since the year 2000, when vascular, cardiac, 
immunological and coagulation dysfunction 
were the most important organ systems 
causing obstetric morbidity.[15] Obstetric 
haemorrhage was the potentially life-
threatening condition most frequently 
encountered in our complex (37.5%), 
and vascular dysfunction as a result of 
hypovolaemia was the most common organ 
system dysfunction seen. The low MI for 
postpartum haemorrhage suggests that 
although postpartum haemorrhage is an 
important problem, the condition is well 
managed by our clinicians.
Of the five potentially life-threatening 
conditions, hypertensive disorders contri-
buted to 7.4% of perinatal deaths. Ninety-three 
per cent of perinatal deaths were not related 
to antepartum and intrapartum maternal life-
threatening conditions, and if postpartum 
maternal life-threatening conditions are 
included, 80% of the women with perinatal 
deaths did not have severe morbidity. These 
findings are consistent with those of Allanson 
et al.[16] describing perinatal mortality in 
Mpumalanga Province, SA, and Vogel et 
al.[17] in the WHO Multicountry Survey, who 
found that a significant proportion of women 
have no recognisable obstetric or medical 
condition at the time of perinatal death. 
Allanson et al.[16] found a rate of maternal 
complications in macerated stillbirths, fresh 
stillbirths and early neonatal deaths of 50.4%, 
Table 7. Comparison of the indices of severe acute morbidity rates at the PAC for the periods  
1997 - 1998, 2002 - 2004 and 2013 - 2014
1997 - 1998 2002 - 2004 2013 - 2014
SMOR iMMR MI SMOR iMMR MI SMOR iMMR MI
Antepartum haemorrhage 1.0 0 0 0.9 1.9 2.1 0.6 0 0
Postpartum haemorrhage 1.4 7.4 5.3 2.1 15.5 7.5 1.2 3.8 3.2
Hypertension 1.5 33.3 22.5 1.57 19.4 12.3 1.6 22.5 13.6
Puerperal sepsis 0.4 7.4 20.0 0.5 5.8 10.7 0.5 0 0
Non-pregnancy-related infections 0.3 22.2 66.7 0.4 19.4 47.6 0.8 22.5 30.0
Medical and surgical disorders 0.8 11.1 14.3 0.8 11.7 14.3 0.8 15.0 19.0
Total (excluding early pregnancy losses) 5.8 96.2 16.6 7.0 85.5 12.2 5.1 71.4 14.0
Total deliveries
26.94/1 000
(n=717)
Non-life-threatening
conditions
23.13/1 000
(n=589)
Potentially
life-threatening
conditions
114.26/1 000
(n=128)
Life-threatening
conditions
198.0/1 000
(n=27)
Near miss
196.6/1 000
(n=23)
Non-near miss
Severe morbidity
102.64/1 000
(n=101)
Maternal death
210/1 000
(n=4)
Fig. 3. Perinatal mortality rate (for babies >500 g).
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50.7% and 25.8%, respectively. The WHO Multicountry Survey found 
a maternal complication rate of 22.9%, 27.7% and 21.2% in late 
macerated stillbirths, late fresh stillbirths and early neonatal deaths, 
respectively. Current early antenatal identification of both severe 
maternal morbidity and perinatal mortality is inadequate.
Study strengths and limitations
The strength of this study is the robust method of data collection. 
The new national birth register records maternal complications, 
facilitating the collection of data. The PAC has been collecting and 
reviewing data on life-threatening conditions for more than 15 
years, and all doctors are familiar with the WHO near-miss criteria. 
Women who were classified as a near miss were interviewed about 
barriers encountered in accessing healthcare. This information will 
be presented in a separate article.
A limitation of this study is the exclusion of cases of early pregnancy 
loss (abortions and ectopic pregnancies). Some cases of sepsis may 
have been missed if patients presented late in the postpartum period. 
Furthermore, maternal infections such as pneumonia, tuberculosis 
and meningitis were not on the list of potentially life-threatening 
conditions, so the SMOR could not be calculated for these disease 
conditions. The list of potentially life-threatening conditions should 
be expanded to include medical conditions and non-pregnancy-
related infections. This is supported by Lumbiganon et al.,[18] who 
demonstrated that indirect causes of maternal deaths are increasingly 
important in developing countries, with indirect causes being 
responsible for about one-fifth of severe maternal outcomes.
Recommendations
• The WHO has identified five potentially life-threatening 
conditions: severe postpartum haemorrhage, severe pre-eclampsia, 
eclampsia, sepsis/severe infection and ruptured uterus.[2] Our 
study has shown that conditions such as abruptio placentae, non-
pregnancy-related infections and medical and surgical disorders 
are also important causes of obstetric morbidity, and the WHO 
should therefore consider expanding its categories of potentially 
life-threatening conditions.
• Forty per cent of patients with life-threatening conditions presented 
to a level 1 or 2 facility before being transferred for tertiary care. 
Cases of postpartum haemorrhage and severe pre-eclampsia 
could not be predicted antenatally. In addition, no recognisable 
obstetric condition was present in the majority of pregnancies 
that ended in a perinatal death. Health workers in level 1 and 2 
centres must therefore be able to recognise, stabilise and transfer 
pregnant women and neonates presenting with an acute obstetric 
emergency.
• Strategies to prevent and screen for pre-eclampsia and improvement 
of emergency transport for women are essential in order to reduce 
obstetric morbidity and mortality.
• Review of the reduced visits protocol put forward by the WHO 
should be considered, as increasing the frequency of antenatal 
visits for low-risk women may increase detection of pre-eclampsia 
at an earlier stage of the disease process.[8] However, this would 
require a considerable increase in resources.
Conclusion
In this study we were able to identify the proportion of pregnancy-
related morbidity in our population and compare it with other studies. 
The MI and prevalence of potentially life-threatening conditions were 
similar to those in the WHO Multicountry Survey. Although there 
has been a decrease in the MI for non-pregnancy-related infection, 
further interventions need to be implemented to reduce morbidity 
and mortality associated with HIV disease and tuberculosis. A 
significant proportion of women who developed severe maternal 
conditions were not identified during the antenatal period, indicating 
the need to ensure that all levels of care can manage the initial steps in 
obstetric and neonatal emergencies and that an efficient emergency 
transport system is available.
References
1. Pattinson RC, ed. Saving Mothers 2011-2013: Sixth Report on Confidential Enquiries into Maternal 
Deaths in South Africa. Pretoria: Department of Health, 2014.
2. World Health Organization. Evaluating the Quality of Care for Severe Pregnancy Complications. The 
WHO Near-miss Approach for Maternal Health. Geneva: WHO Press, 2011.
3. Pattinson RC, Hall MH. Near Misses: A useful adjunct to maternal death enquiries. Br Med Bull 
2003;67(1):231-243. [http://dx.doi.org/10.1093/bmb/ldg007]
4. Chhabra P. Maternal near miss: An indicator for maternal health and maternal care. Indian J 
Community Med 2014;39(3):132-137. [http://dx.doi.org/10.4103/0970-0218.137145]
5. Souza JP, Gulmezoglu AM, Vogel J, et al. Moving beyond essential interventions for reduction of 
maternal morbidity (the WHO Multicountry Survey on Maternal and Newborn Health): A cross-
sectional study. Lancet 2013;381(9879):1747-1755. [http://dx.doi.org/10.1016/S0140-6736(13)60686-8]
6. Say L, Souza JP, Pattinson RC. Maternal near-miss – towards a standard tool for monitoring quality of 
maternal care. Best Pract Res Clin Obstet Gynaecol 2009;23(3):287-296. [http://dx.doi.org/10.1016/j.
bpobgyn.2009.01.007]
7. Pattinson RC, Macdonald AP, Backer F, Kleynhans M. Effect of audit on critically ill pregnant 
women. Clinical Governance: An International Journal 2006;11(4):278-288. [http://dx.doi.
org/10.1108/14777270610708814.
8. Birthplace in England Collaborative Group. Perinatal and maternal outcomes by planned place of birth 
for healthy women with low risk pregnancies: The Birthplace in England national prospective cohort 
study. BMJ 2011;343:d7400. [http://dx.doi.org/10.1136/bmj.d7400]
9. Villar J, Bergsjo P. WHO Antenatal Care Randomised Trial: Manual for the Implementation of the New 
Model. Geneva: WHO, 2003.
10. Dowswell T, Carroli G, Duley L, et al. Alternative versus standard packages of antenatal care for low-
risk pregnancy (Review). Cochrane Database Syst Rev 2010, Issue 10. Art. No.: CD000934. [http://
dx.doi.org/10.1002/14651858.CD000934.pub2]
11. Vandecruys HIB, Pattinson RC, Macdonald AP, Mantel GD. Severe acute maternal morbidity and 
mortality in the Pretoria Academic Complex: Changing patterns over 4 years. Eur J Obstet Gynecol 
Reprod Biol 2002;102(1):6-10. [http://dx.doi.org/10.1016/S0301-2115(01)00558-9]
12. Lombaard H, Pattinson RC. Common errors and remedies in managing postpartum haemorrhage. 
Best Pract Res Clin Obstet Gynaecol 2009;23(3):317-326. [http://dx.doi.org/10.1016/j.
bpobgyn.2009.01.006]
13. Daru PH, MU J, Achara P, et al. Near miss maternal mortality in Jos University Teaching Hospital, Jos, 
Plateau State Nigeria. Ibom Medical Journal 2008;3(1):18-21.
14. David E, Machungo F, Zanconato G et al. Maternal near miss and maternal deaths in Mozambique: 
A cross sectional, region-wide study of 635 consecutive cases assisted in health facilities of Maputo 
Province. BMC Pregnancy Childbirth 2014;14:401. [http://dx.doi.org/10.1186/s12884-014-0401-3]
15. Mantel GD, Buchmann E, Rees H, Pattinson RC. Severe acute maternal morbidity: A pilot study of a 
definition for a near-miss. BJOG 1998;105(9):985-990. [http://dx.doi.org/10.1111/j. 1471-0528]
16. Allanson ER, Muller M, Pattinson RC. Causes of perinatal mortality and associated maternal 
complications in a South African province: Challenges in predicting poor outcomes. BMC Pregnancy 
Childbirth 2015;15:37. [http://dx.doi.org/10.1186/s12884-015-0472-9]
17. Vogel JP, Souza JP, Mori R, et al. Maternal complications and perinatal mortality: Findings of the World 
health Organisation Multicountry Survey on Maternal and Newborn Health. BJOG 2014;121(Suppl. 
1):76-88. [http://dx.doi.org/10.1111/1471-0528.12633]
18. Lumbiganon P, Laopaiboon M, Intarut N, et al. Indirect causes of severe adverse maternal outcomes: 
A secondary analysis of the WHO Multicountry Survey on Maternal and Newborn Health. BJOG 
2014;121(Suppl. 1):32-39. [http://dx.doi.org/10.1111/1471-0528.12647]
Accepted 27 March 2015.
